Simbec-Orion Group

Executive Summary

Simbec-Orion Group is a UK-based contract research organization (CRO) with nearly 50 years of experience in managing complex clinical trials across early to late phases. The company specializes in rare diseases and oncology, offering integrated services including clinical trial management, clinical pharmacology, central laboratory support, and regulatory affairs. As a private company with a strong reputation in the CRO space, Simbec-Orion benefits from increasing demand for outsourced clinical development services, particularly in niche therapeutic areas. Its long-standing presence and expertise position it well to capture growth in a fragmented market, though visibility is limited due to its private status.

Upcoming Catalysts (preview)

• TBDExpansion into U.S. or European markets through strategic partnerships or acquisitions50% success
• TBDMajor contract wins from large pharma or biotech clients in rare disease or oncology60% success
• TBDLaunch of new service capabilities (e.g., decentralized trials or biomarker analytics)40% success